
|Videos|May 30, 2022
Vitamin D deficiency is associated with prostate tumor gene expression
Author(s)Urology Times staff
“I think the one thing that we're hopeful for is that people will start to look at vitamin D as a potential chemoprevention agent,” says Adam B. Murphy, MD, MBA, MSCI.
Advertisement
In this video, Adam B. Murphy, MD, MBA, MSCI, discusses the key findings from the study, “Vitamin D has a stronger impact on prostate tumor gene expression in Black men,” which he presented at the 2022 American Urological Association annual meeting in New Orleans, Louisiana. Murphy is an assistant professor of urology and preventive medicine (cancer epidemiology and prevention) at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












